BioCardia Inc
NASDAQ:BCDA
BioCardia Inc
Revenue
BioCardia Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BioCardia Inc
NASDAQ:BCDA
|
Revenue
$477k
|
CAGR 3-Years
47%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
6%
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
See Also
What is BioCardia Inc's Revenue?
Revenue
477k
USD
Based on the financial report for Dec 31, 2023, BioCardia Inc's Revenue amounts to 477k USD.
What is BioCardia Inc's Revenue growth rate?
Revenue CAGR 10Y
6%
Over the last year, the Revenue growth was -65%. The average annual Revenue growth rates for BioCardia Inc have been 47% over the past three years , -5% over the past five years , and 6% over the past ten years .